Yüklüyor......
Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial
BACKGROUND: Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be excessi...
Kaydedildi:
| Yayımlandı: | J Vet Intern Med |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8295656/ https://ncbi.nlm.nih.gov/pubmed/34114259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16195 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|